Management of localized scleroderma.

N Hunzelmann, C Hager, T Krieg - Seminars in cutaneous …, 1998 - europepmc.org
Localized scleroderma denotes a spectrum of conditions characterized by circumscribed
fibrotic areas involving different levels of the dermis, subcutis, and sometimes underlying soft …

Scleroderma in children

F Zulian - Pediatric Clinics, 2005 - pediatric.theclinics.com
Juvenile scleroderma syndromes are multisystem autoimmune rheumatic diseases whose
unifying characteristic is the presence of hard skin and onset before 16 years of age. They …

Extended extracorporeal photochemotherapy with extracorporeal administration of 8‐methoxypsoralen in systemic sclerosis. An Austrian single‐center study

RR Muellegger, A Hofer, W Salmhofer… - Photodermatology …, 2000 - Wiley Online Library
Background: Extracorporeal photochemotherapy (EXP) is an immunomodulating therapy
that has been used in a limited number of patients with systemic sclerosis (SSC) with …

Photopheresis: advances and use in systemic sclerosis

XA Zhou, J Choi - Current rheumatology reports, 2017 - Springer
Abstract Purpose of Review Extracorporeal photochemotherapy (photopheresis, ECP) is a
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …

Surfactant Protein D (SP‐D) and Systemic Scleroderma (SSc)

M Maeda, Y Ichiki, Y Aoyama… - The Journal of …, 2001 - Wiley Online Library
We measured serum levels of SP‐D in collagen diseases (110 cases) such as systemic
scleroderma (SSc), scleroderma spectrum disorders (SSD), systemic lupus erythematodes …

Photopheresis and autoimmune diseases

MD Mayes - Rheumatic Disease Clinics of North America, 2000 - Elsevier
Although several case reports and case series have suggested efficacy for photopheresis in
the treatment of autoimmune diseases, few controlled studies have been conducted to test …

Extracorporeal photopheresis in systemic sclerosis: effects on organ involvement?

S Reich, T Gambichler, P Altmeyer, A Kreuter - Journal of the American …, 2007 - jaad.org
To the Editor: Faced with the often disappointing outcome of therapeutic interventions in
systemic sclerosis (SSc), we read with great interest the article of Knobler et al 1 published …

Cutaneous and noncutaneous disorders treated with extracorporeal photopheresis.

GG Russo, C Mullen - International journal of dermatology, 2001 - search.ebscohost.com
Reports on extracorporeal photopheresis, the use of leukopheresis with a leukocyte-rich cell
extract to treat cutaneous and noncutaneous disorders. Depletion of the leukocytes from the …

Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art

M Martino, R Fedele, G Cornelio… - Expert Opinion on …, 2012 - Taylor & Francis
Introduction: Extracorporeal photopheresis (ECP) has been extensively used for the
treatment of immune-mediated diseases for over 20 years and has a consistent and …

[PDF][PDF] Extracorporeal photoimmunotherapy-photopheresis

T Dani, R Knobler - Front Biosci, 2009 - article.imrpress.com
[Frontiers in Bioscience 14, 4769-4777, January 1, 2009] 4769 Extracorporeal
photoimmunotherapy-photopheresis Theresa Dani1, Rob Page 1 [Frontiers in Bioscience 14 …